STAT+: Lilly shares safety, tolerability data on its next-gen obesity drug
Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association on Saturday.
Read full article →Latest Healthcare Policy news from across the web.
Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association on Saturday.
Read full article →Detailed data from a midstage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could be dosed monthly.
Read full article →In Virunga National Park, rangers are on the front lines — playing a critical role to contain the surging virus while coping with an upsurge in conflict-related violence.
Read full article →“Ebola is an unforgiving enemy,” writes Tom Frieden, who led the U.S. CDC response to the 2014-2016 Ebola outbreak.
Read full article →There may be nearly 2 million Amish Americans by 2075. That has large public health implications.
Read full article →The Ebola outbreak in Central Africa could grow to 20,000 cases or more, depending on how quickly infected people are isolated to slow the spread, according to a new U.S. analysis.
Read full article →You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New Orleans.
Read full article →Thousands of HHS staff who shape policy have had their employment status changed to a designation that makes it easier for them to be fired.
Read full article →New modeling from the CDC shows that if measures aren't taken immediately, this outbreak could sicken more than 20,000 people in the next three months.
Read full article →An NIH advisor told researchers gathered at the American Diabetes Association conference that MAHA goals match the agency's priorities.
Read full article →Outbreak response is difficult enough without asking responders to wonder whether they will have access to the best available care if they become ill.
Read full article →A new twice-yearly HIV prevention injection could transform South Africa's fight against the epidemic — but U.S. aid cuts and limited doses threaten to slow its impact.
Read full article →